Articles in this volume address coerced drug treatment, the Convention on the Rights of the Child, the INCB and ayahuasca, and the death penalty for drug in China.
At different points in history, drug production, use and supply have all been presented as threats to security whether human, national or international security.
The meeting focused on the international drug control structures and the UN drug control conventions, the Austrian drug policy with special reference to young people who use drugs, and the work plan of the SEE Network for the coming year.
This is a year-long study of the current security situation on the U.S.-Mexico border and the impact of both countries' security policies on the migrant population.
Welcome to this treatment guide for HIV-positive people who also have hepatitis B (HBV). This guide provides information on the prevention, care, and treatment of HBV, and the impact of HBV on HIV disease. It is designed to be accessible to people with no medical training.
Мы приветствуем всех читателей нашего справочника. Информация, которая в нем содержится, рассчитана, главным образом, на ВИЧ-положительных людей, у которых также диагностирован гепатит В. Справочник содержит информацию по профилактике, лечению и уходу при ВГВ, а также по воздействию ВГВ на течение ВИЧ-инфекции. Издание составлено таким образом, чтобы быть доступным для людей без медицинского образования.
Across Europe information-only prevention approaches - despite a weak evidence for their effectiveness - continue to be most commonly used. Why this is the case is the question addressed by this editorial.
By Nigel Inkster and Virginia Comolli
The world’s wealthiest nations have expended vast blood and treasure in tracking and capturing traffickers, dealers and consumers of narcotics, as well as destroying crops and confiscating shipments. Yet the global trade in illicit drugs is thriving, with no apparent change in the level of consumption despite decades of prohibition. This Adelphi argues that the present enforcement regime is not only failing to win the ‘War on Drugs’; it is also igniting and prolonging that conflict on the streets of producer and transit countries, where the supply chain has become interwoven with state institutions and cartels have become embroiled in violence against their rivals and with security forces.
What can be done to secure the worst affected regions and states, such as Latin America and Afghanistan? By examining the destabilising effects of prohibition, as well as alternative approaches such as that adopted by the authorities in Portugal, this book shows how progress may be made by treating consumption as a healthcare issue rather than a criminal matter, thereby freeing states to tackle the cartels and traffickers who hold their communities to ransom.
The full document is available here.
Nigel Inkster is Director of Transnational Threats and Political Risk, IISS.
Virginia Comolli is Research Associate for Transnational Threats at the IISS.
‘The unintended consequences of the global drugs control regime have been felt most keenly in fragile and failing states which have seen their security threatened and their institutions subverted by criminal networks competing for the massive profits generated by an international black market in illicit substances. IISS provides a detailed and dispassionate analysis of this phenomenon and highlights the need to consider alternative approaches.’
Fernando Henrique Cardoso, former President of Brazil; Chair, Global Commission on Drug Policy
‘A sober, thorough and elegant assessment of the War on Drugs and why it has failed so badly. When venerable institutions like the IISS bring their considerable gravitas to this debate in such a forceful manner, then it is surely a sign that the time has come for a fundamental rethink of this policy.’
Misha Glenny, journalist and author of McMafia: A Journey through the Global Criminal Underworld
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.
This report has been compiled by the EMCDDA in the first half of 2011 as a supporting document for the external evaluation of the 2005–12 EU drugs strategy and its two 2005–08 and 2009–12 action plans.
RAND Europe undertook an independent evaluation of the current 2005-2012 EU Drugs Strategy and its Action Plans, addressing four main research objectives.
